Europe Medical Enzyme Technology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Enzyme Type (Digestive Enzymes, Thrombolytic Enzymes, Hydrolases, and Endonucleases); Application (Disease Treatment, Diagnostic Tools, Biomedical Research, and Others)
Market Introduction
Enzymes are proteins produced in living cells of plants, animals, and microorganisms. All living organisms require enzymes for growth and for the production and utilization of energy which is essential for life. In the living cell, enzymes act as catalysts to speed up the chemical reactions which control life processes. Enzymes have been significant industrial products for more than a hundred years. However, the range of potential applications is increasing rapidly. With the advent of recombinant DNA technology, it has become possible to make formerly rare enzymes in large quantities and hence to reduce cost. Also, in pharmaceutical manufacturing, the desire to make chirally pure compounds is leading to new opportunities. Technological advances have facilitated the use of enzymes over an increasingly broad range of process conditions.
Thus, the significant increase in research and development activities is expected to create a significant demand for medical enzyme technology in the coming years, which is further anticipated to drive the medical enzyme technology market.
Countries in the European regions were profoundly affected due to the COVID-19 pandemic. For instance, countries such as Italy, Spain, and France have reported the highest number of positive cases and have registered the maximum number of deaths. European countries are observing a resurgence in COVID-19 cases after successfully mitigating outbreaks early in the year. Many countries are declaring more cases each day now than during the first wave earlier this year. Lockdowns are being reintroduced in the UK, Spain, Italy, and Ireland, as per the European Centre for Disease Prevention and Control (ECDC). Meanwhile, Europe is attempting to rebound from the COVID-19 crises' impact on citizens' health and its economy's stability. New policies in the European Green Deal would try to mitigate the pandemic's effects. Biotechnology can be a valuable tool in this recovery, from modern plant breeding methods that help us meet the goals of the Farm to Fork Strategy to pharmaceutical and medical innovations that allow us to stop the pandemic. Biotechnology in agriculture has improved animal nutrition, developed vaccines for animals, and improved diagnostics for BSE, foot-and-mouth disease, and salmonella. It has also made it possible to use enzymes. Hence, the European genomic market is likely to show significant growth prospects during this pandemic and forecasted year.
Get more information on this report :
Market Overview and Dynamics
The Medical enzyme technology market in Europe is expected to grow from US$ 1,164.5 million in 2021 to US$ 1,799.6 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028. Biopharmaceuticals are among the growing business segments of the pharmaceutical and biotechnology industries. Since their introduction in 1982, biopharmaceutical drugs have revolutionized the treatment of a broad spectrum of diseases, and they are increasingly used in nearly all medicine branches. Despite the immense time and financial effort required, the market of biopharmaceuticals is rapidly growing.
Key Market Segments
In terms of enzyme type, the hydrolases segment accounted for the largest share of the Europe medical enzyme technology market in 2020. In terms of application, the disease treatment segment accounted for the largest share of the Europe medical enzyme technology market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the medical enzyme technology market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Merck Kgaa, Thermo Fisher Scientific Inc., Novozymes, Takeda Pharmaceutical Company Limited, Agilent Technologies, Inc., Genzyme Corporation, Asahi Kasei Corporation, Promega Corporation, Cytiva, and Amano Enzyme Inc.
Reasons to buy report
- To understand the Europe Medical enzyme technology market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe Medical enzyme technology market
- Efficiently plan M&A and partnership deals in Europe Medical enzyme technology market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe Medical enzyme technology market
- Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.
EUROPE MEDICAL ENZYME TECHNOLOGY MARKET SEGMENTATION
By Enzyme Type
- Digestive Enzymes
- L-asparaginase
- Lactase
- Others
- Thrombolytic Enzymes
- Streptokinase
- Urokinase
- Others
- Hydrolases Enzymes
- Hyaluronidase
- Lysozymes
- Others
- Endonucleases Enzymes
- Benzonase
- Others
By Application
- Disease Treatment
- Diagnostic Tools
- Biomedical Research
- Others
By Country
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Companies Mentioned
- Merck Kgaa
- Thermo Fisher Scientific Inc.
- Novozymes
- Takeda Pharmaceutical Company Limited
- Agilent Technologies, Inc.
- Genzyme Corporation
- Asahi Kasei Corporation
- Promega Corporation
- Cytiva
- Amano Enzyme Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Medical Enzyme Technology Market – By Enzyme Type
1.3.2 Medical Enzyme Technology Market – By Application
1.3.3 Europe Medical Enzyme Technology Market – By Country
2. Europe Medical Enzyme Technology Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Medical Enzyme Technology Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Medical Enzyme Technology Market- Europe PEST Analysis
4.3 Expert Opinion
5. Europe Medical Enzyme Technology Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Applications of Enzymes in Diagnosis and Disease Treatment
5.1.2 Significant Increase in Research and Development Activities
5.2 Market Restraints
5.2.1 Handling and Safety Issues Related to Enzymes
5.3 Market Opportunities
5.3.1 Rising Production of Biopharmaceutical Products
5.4 Future Trends
5.4.1 Advancements in Enzyme Engineering
5.5 Impact Analysis
6. Medical Enzyme Technology Market – Europe Analysis
6.1 Europe Medical Enzyme Technology Market Revenue Forecasts and Analysis
7. Europe Medical Enzyme Technology Market Analysis and Forecasts To 2028 – By Enzyme Type
7.1 Overview
7.2 Medical Enzyme Technology Market Revenue Share, by Enzyme Type (2020–2028)
7.3 Digestive Enzymes
7.3.1 Overview
7.3.2 Digestive Enzymes: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 L-asparaginase Market
7.3.3.1 Overview
7.3.3.2 L-asparaginase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Lactase Market
7.3.4.1 Overview
7.3.4.2 Lactase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Others Market
7.3.5.1 Overview
7.3.5.2 Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Thrombolytic Enzymes
7.4.1 Overview
7.4.2 Thrombolytic Enzymes: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Streptokinase Market
7.4.3.1 Overview
7.4.3.2 Streptokinase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Urokinase Market
7.4.4.1 Overview
7.4.4.2 Urokinase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Others Market
7.4.5.1 Overview
7.4.5.2 Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Hydrolases Enzymes
7.5.1 Overview
7.5.2 Hydrolases: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.3 Hyaluronidase Market
7.5.3.1 Overview
7.5.3.2 Hyaluronidase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.4 Lysozymes Market
7.5.4.1 Overview
7.5.4.2 Lysozymes: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.5 Others Market
7.5.5.1 Overview
7.5.5.2 Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Endonucleases
7.6.1 Overview
7.6.2 Endonucleases: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.6.3 Benzonase
7.6.3.1 Overview
7.6.3.2 Benzonase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.6.4 Others
7.6.4.1 Overview
7.6.4.2 Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
8. Medical Enzyme Technology Market Analysis – By Application
8.1 Overview
8.2 Medical Enzyme Technology Market Revenue Share, by Application (2020–2028)
8.3 Disease Treatment
8.3.1 Overview
8.3.2 Disease Treatment: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostic Tools
8.4.1 Overview
8.4.2 Diagnostic Tools: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Biomedical Research
8.5.1 Overview
8.5.2 Biomedical Research: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
9. Medical Enzyme Technology Market Revenue and Forecasts to 2028 – Geographical Analysis
9.1 Europe: Medical Enzyme Technology Market
9.1.1 Overview
9.1.1.1 Europe: Medical Enzyme Technology Market, by Country, 2020 & 2028(%)
9.1.1.2 Germany: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.1 Germany: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2 Germany Medical Enzyme Technology Market, by Enzyme Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2.1 Germany Digestive Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2.2 Germany Thrombolytic Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2.3 Germany Hydrolases Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2.4 Germany Endonucleases Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.3 Germany Medical Enzyme Technology Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.3 UK: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.1 UK: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2 UK Medical Enzyme Technology Market, by Enzyme Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2.1 UK Digestive Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2.2 UK Thrombolytic Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2.3 UK Hydrolases Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2.4 UK Endonucleases Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.3 UK Medical Enzyme Technology Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.4 France: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.1 France: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2 France Medical Enzyme Technology Market, by Enzyme Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2.1 France Digestive Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2.2 France Thrombolytic Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2.3 France Hydrolases Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2.4 France Endonucleases Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.3 France Medical Enzyme Technology Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.5 Spain: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.1 Spain: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.2 Spain Medical Enzyme Technology Market, by Enzyme Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.2.1 Spain Digestive Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.2.2 Spain Thrombolytic Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.2.3 Spain Hydrolases Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.2.4 Spain Endonucleases Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.3 Spain Medical Enzyme Technology Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.6 Italy: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.1 Italy: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.2 Italy Medical Enzyme Technology Market, by Enzyme Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.2.1 Italy Digestive Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.2.2 Italy Thrombolytic Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.2.3 Italy Hydrolases Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.2.4 Italy Endonucleases Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.3 Italy Medical Enzyme Technology Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.7 Rest of Europe: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.7.1 Rest of Europe: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.7.2 Rest of Europe Medical Enzyme Technology Market, by Enzyme Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.7.2.1 Rest of Europe Digestive Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.7.2.2 Rest of Europe Thrombolytic Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.7.2.3 Rest of Europe Hydrolases Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.7.2.4 Rest of Europe Endonucleases Market, by Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.7.3 Rest of Europe Medical Enzyme Technology Market, by Application – Revenue and Forecast to 2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Europe Medical Enzyme Technology Market
10.1 Europe: Impact Assessment of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.3.2 Organic Developments Done by Companies
11.4 Inorganic Developments
11.4.1 Overview
11.4.2 Inorganic Developments Done by Companies
12. COMPANY PROFILES
12.1 MERCK KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 THERMO FISHER SCIENTIFIC INC.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Novozymes
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Takeda Pharmaceutical Company Limited
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Agilent Technologies, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Genzyme Corporation
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Asahi Kasei Corporation
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Promega Corporation
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Cytiva
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Amano Enzyme Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany Medical Enzyme Technology Market, by Enzyme Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Germany Digestive Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 3. Germany Thrombolytic Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 4. Germany Hydrolases Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 5. Germany Endonucleases Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 6. Germany Medical Enzyme Technology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. UK Medical Enzyme Technology Market, by Enzyme Type – Revenue and Forecast to 2028 (USD Million)
Table 8. UK Digestive Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 9. UK Thrombolytic Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 10. UK Hydrolases Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 11. UK Endonucleases Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 12. UK Medical Enzyme Technology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. France Medical Enzyme Technology Market, by Enzyme Type – Revenue and Forecast to 2028 (USD Million)
Table 14. France Digestive Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 15. France Thrombolytic Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 16. France Hydrolases Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 17. France Endonucleases Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 18. France Medical Enzyme Technology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 19. Spain Medical Enzyme Technology Market, by Enzyme Type – Revenue and Forecast to 2028 (USD Million)
Table 20. Spain Digestive Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 21. Spain Thrombolytic Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 22. Spain Hydrolases Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 23. Spain Endonucleases Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 24. Spain Medical Enzyme Technology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 25. Italy Medical Enzyme Technology Market, by Enzyme Type – Revenue and Forecast to 2028 (USD Million)
Table 26. Italy Digestive Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 27. Italy Thrombolytic Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 28. Italy Hydrolases Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 29. Italy Endonucleases Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 30. Italy Medical Enzyme Technology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 31. Rest of Europe Medical Enzyme Technology Market, by Enzyme Type – Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of Europe Digestive Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Europe Thrombolytic Enzymes Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 34. Rest of Europe Hydrolases Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 35. Rest of Europe Endonucleases Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 36. Rest of Europe Medical Enzyme Technology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 37. Glossary of Terms, Medical Enzyme Technology Market
LIST OF FIGURES
Figure 1. Medical Enzyme Technology Market Segmentation
Figure 2. Europe Medical Enzyme Technology Market Overview
Figure 3. Hydrolases Segment Held Largest Share of Enzyme Type in Medical Enzyme Technology Market
Figure 4. UK is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Medical Enzyme Technology Market - Europe PEST Analysis
Figure 6. Medical Enzyme Technology Market Impact Analysis of Driver and Restraints
Figure 7. Europe Medical Enzyme Technology Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Medical Enzyme Technology Market Revenue Share, by Enzyme Type (2020–2028)
Figure 9. Digestive Enzymes: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. L-asparaginase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Lactase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Thrombolytic Enzymes: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Streptokinase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Urokinase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Hydrolases: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Hyaluronidase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Lysozymes: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Endonucleases: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Benzonase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Medical Enzyme Technology Market Revenue Share, by Application (2020–2028)
Figure 25. Disease Treatment: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Diagnostic Tools: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Biomedical Research: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Europe: Medical Enzyme Technology Market, by Key Country – Revenue (2020) (USD Million)
Figure 30. Europe: Medical Enzyme Technology Market, by Country, 2020 & 2028(%)
Figure 31. Germany: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. UK: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. France: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Spain: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Italy: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Rest of Europe: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Impact of COVID-19 Pandemic in European Country Markets
Figure 38. Growth Strategies Done by the Companies in the Market, (%)
- Merck Kgaa
- Thermo Fisher Scientific Inc.
- Novozymes
- Takeda Pharmaceutical Company Limited
- Agilent Technologies, Inc.
- Genzyme Corporation
- Asahi Kasei Corporation
- Promega Corporation
- Cytiva
- Amano Enzyme Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe medical enzyme technology market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe medical enzyme technology market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the medical enzyme technology market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution